ArticleOncotarget2017

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium.

Shanly C Seferina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.